[Form 4] Vontier Corporation Insider Trading Activity

Rhea-AI Filing Summary

The filing shows that Kathryn K. Rowen, SVP and Chief Administrative Officer of Vontier Corp (VNT), reported a sale of 667 shares of Vontier common stock on 08/15/2025 at a reported price of $42.11 per share. After this transaction she beneficially owned 87,581 shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.

Positive

• Timely disclosure of the insider sale fulfilling Section 16 reporting requirements
• Clear post-transaction ownership reported (87,581 shares), aiding transparency

Negative

• Insider sale of 667 shares could be viewed negatively by some investors despite modest size
• No explicit Rule 10b5-1 plan or explanatory remark provided to clarify the reason for the sale

Insights

Securities Analyst

TL;DR: Routine insider sale reported by an executive; small divestiture with no additional context provided.

The sale of 667 shares at $42.11 appears to be a straightforward disposal by a named officer rather than a large, unusual divestiture. The report includes the post-transaction beneficial ownership of 87,581 shares, which helps assess remaining insider alignment with shareholders. There are no derivative transactions or explanatory remarks to indicate a contractual plan or unusual circumstance. Impact on valuation or control is likely minimal given the modest size of the sale as reported.

Corporate Governance Expert

TL;DR: Filing meets disclosure requirements; lacks detail on whether sale was pre-scheduled.

The Form 4 was properly executed and discloses officer status and the sale specifics, which satisfies Section 16 reporting. However, the filing does not indicate a Rule 10b5-1 trading plan or other authorization that would explain the timing. Without that detail, the transaction is recorded transparently but leaves investors without context on whether the sale was routine portfolio management or timed for other reasons.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rowen Kathryn K.

(Last) (First) (Middle)

C/O VONTIER CORP

5438 WADE PARK BOULEVARD, SUITE 600

(Street)

RALEIGH NC 27607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vontier Corp [ VNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Admin. Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	08/15/2025		F		667	D	$42.11	87,581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Courtney Kamlet, as attorney-in-fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did VNT insider Kathryn Rowen report on Form 4?

The filing reports a sale of 667 shares of Vontier (VNT) common stock on 08/15/2025 at $42.11 per share, leaving her with 87,581 shares beneficially owned.

When was the Form 4 for VNT signed and filed?

The signature on the Form 4 is dated 08/18/2025; the reported transaction date is 08/15/2025.

Does the Form 4 show any option exercises or derivative transactions for VNT?

No. Table II for derivative securities contains no entries; only a non-derivative sale of common stock is reported.

Is there disclosure that the sale was part of a Rule 10b5-1 trading plan?

The filing does not include any notation indicating the transaction was made pursuant to a Rule 10b5-1 plan.